ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

Bandhan Healthcare Fund

BANDHAN Bandhan Mutual Fund Nov 2025 — Sep 2026 11 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹305 CrAt NSE closes, Sep 2026
Companies held3535 with an NSE price
Top 10 holdings54.5%Of the equity shown here
Largest holding10.4%Sun Pharmaceutical Industries Limited
12-month turnover53.0%Estimated from 10 monthly disclosures · compare

Days to sell half: 0.9 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

11 priced months, Nov 2025 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

54.5% now · highest 73.1%, lowest 53.7%

Companies held

35 now · largest single holding 10.4% of equity

How it trades: no clear lean toward recent winners or losers (score -0.15 over 6 months; −1 always buys the biggest fallers, +1 the biggest risers, 0 no pattern). Value and contra funds average −0.10, other active funds about 0. A description of behaviour, not of results. How this was tested →

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. EODWHFEdelweiss · 17 shared61.1%
  2. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 21 shared61.0%
  3. Motilal Oswal BSE Healthcare ETFMotilal Oswal · 34 shared59.8%
  4. Bandhan BSE Healthcare Index FundBandhan · 34 shared59.8%
  5. Axis NIFTY Healthcare ETFAxis · 13 shared57.8%
  6. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 13 shared57.8%
  7. DSP Nifty Healthcare Index FundDSP · 13 shared57.8%
  8. DSP Nifty Healthcare ETFDSP · 13 shared57.8%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 0 Companies added
Complete exits 0 Companies sold out
Increases 6 More shares than last month
Reductions 5 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 10.41% 31.79 Cr 0.02 Cr by Nov 2025 (11 mo+)
Cipla Limited Healthcare Large Cap 6.61% 20.19 Cr 0.01 Cr by Nov 2025 (11 mo+)
Apollo Hospitals Enterprise Limited Healthcare Large Cap 6.15% 18.78 Cr 23,000 by Nov 2025 (11 mo+)
Max Healthcare Institute Limited Healthcare Large Cap 5.63% 17.20 Cr 0.02 Cr by Nov 2025 (11 mo+)
Lupin Limited Healthcare Mid Cap 4.65% 14.21 Cr 70,000 Dec 2025 (10 mo)
Divi's Laboratories Limited Healthcare Large Cap 4.56% 13.94 Cr 15,000 by Nov 2025 (11 mo+)
Shilpa Medicare Limited Healthcare Small Cap 4.46% 13.61 Cr 0.01 Cr Dec 2025 (10 mo)
Aurobindo Pharma Limited Healthcare Mid Cap 4.38% 13.38 Cr 80,000 by Nov 2025 (11 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 4.04% 12.33 Cr 0.01 Cr by Nov 2025 (11 mo+)
GlaxoSmithKline Pharmaceuticals Limited Healthcare Mid Cap 3.63% 11.08 Cr 40,000 by Nov 2025 (11 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 3.46% 10.56 Cr 22,000 Jul 2026 (3 mo)
Gland Pharma Limited Healthcare Small Cap 3.32% 10.15 Cr 35,000 Aug 2026 (2 mo)
Zydus Lifesciences Limited Healthcare Mid Cap 3.02% 9.22 Cr 79,327 May 2026 (5 mo)
Narayana Hrudayalaya Ltd. Healthcare Mid Cap 2.93% 8.96 Cr 50,000 May 2026 (5 mo)
Syngene International Limited Healthcare Small Cap 2.63% 8.04 Cr 0.02 Cr by Nov 2025 (11 mo+)
Rainbow Childrens Medicare Limited Healthcare Small Cap 2.37% 7.23 Cr 55,000 by Nov 2025 (11 mo+)
Eris Lifesciences Limited Healthcare Small Cap 2.34% 7.15 Cr 60,000 Apr 2026 (6 mo)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 2.29% 7.00 Cr 30,000 by Nov 2025 (11 mo+)
Global Health Limited Healthcare Mid Cap 2.01% 6.14 Cr 45,000 Dec 2025 (10 mo)
Novartis India Limited Not classified Small Cap 2.01% 6.13 Cr 31,934 May 2026 (5 mo)
Pfizer Limited Healthcare Small Cap 1.65% 5.04 Cr 13,000 by Nov 2025 (11 mo+)
Sanofi India Limited Not classified Small Cap 1.60% 4.89 Cr 16,000 Dec 2025 (10 mo)
IPCA Laboratories Limited Healthcare Mid Cap 1.58% 4.82 Cr 25,000 Feb 2026 (8 mo)
Healthcare Global Enterprises Limited Healthcare Small Cap 1.42% 4.33 Cr 65,000 Dec 2025 (10 mo)
Thyrocare Technologies Limited Healthcare Small Cap 1.40% 4.27 Cr 80,000 Apr 2026 (6 mo)
Jubilant Pharmova Limited Healthcare Small Cap 1.35% 4.12 Cr 40,000 Aug 2026 (2 mo)
Ajanta Pharma Limited Healthcare Small Cap 1.30% 3.98 Cr 11,000 by Nov 2025 (11 mo+)
Sai Life Sciences Limited Healthcare Small Cap 1.25% 3.81 Cr 25,000 by Nov 2025 (11 mo+)
Sai Parenterals Limited Not classified — 1.23% 3.75 Cr 70,830 Jul 2026 (3 mo)
Alivus Life Sciences Limited Not classified Small Cap 1.23% 3.75 Cr 27,172 May 2026 (5 mo)
AstraZeneca Pharma India Limited Not classified Small Cap 1.22% 3.71 Cr 6,000 Aug 2026 (2 mo)
Orchid Pharma Limited Not classified Small Cap 1.21% 3.69 Cr 37,000 Dec 2025 (10 mo)
Dr. Lal Path Labs Ltd. Healthcare Small Cap 0.98% 2.98 Cr 15,000 by Nov 2025 (11 mo+)
Medi Assist Healthcare Services Limited Not classified Small Cap 0.89% 2.72 Cr 90,000 Dec 2025 (10 mo)
Viyash Scientific Limited Healthcare Small Cap 0.83% 2.53 Cr 0.01 Cr Jun 2026 (4 mo)

Half of its current holdings have been held for 10 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Syngene International Limited Sep 2026 ▲ Increasing +20,000
Jubilant Pharmova Limited Sep 2026 ▼ Reducing -15,000
Sai Parenterals Limited Sep 2026 ▲ Increasing +10,000
Healthcare Global Enterprises Limited Sep 2026 ▼ Reducing -10,000
Global Health Limited Sep 2026 ▼ Reducing -10,000
Lupin Limited Sep 2026 ▲ Increasing +10,000
Narayana Hrudayalaya Ltd. Sep 2026 ▲ Increasing +5,000
Ajanta Pharma Limited Sep 2026 ▼ Reducing -5,000
Alivus Life Sciences Limited Sep 2026 ▼ Reducing -5,000
Rainbow Childrens Medicare Limited Sep 2026 ▲ Increasing +5,000
Apollo Hospitals Enterprise Limited Sep 2026 ▲ Increasing +2,000
Max Healthcare Institute Limited Aug 2026 ▲ Increasing +85,000
Jubilant Pharmova Limited Aug 2026 ▲ New position +55,000
Dr. Lal Path Labs Ltd. Aug 2026 ▼ Reducing -43,000
Syngene International Limited Aug 2026 ▲ Increasing +40,000
Lupin Limited Aug 2026 ▲ Increasing +37,500
Gland Pharma Limited Aug 2026 ▲ New position +35,000
Global Health Limited Aug 2026 ▼ Reducing -27,000
Healthcare Global Enterprises Limited Aug 2026 ▼ Reducing -25,000
Narayana Hrudayalaya Ltd. Aug 2026 ▲ Increasing +20,000
Glenmark Pharmaceuticals Limited Aug 2026 ▼ Reducing -20,000
Orchid Pharma Limited Aug 2026 ▼ Reducing -18,000
Eris Lifesciences Limited Aug 2026 ▲ Increasing +14,727
Ajanta Pharma Limited Aug 2026 ▼ Reducing -11,000
IPCA Laboratories Limited Aug 2026 ▼ Reducing -10,000
Concord Biotech Limited Aug 2026 ▼ Complete exit -10,000
GlaxoSmithKline Pharmaceuticals Limited Aug 2026 ▲ Increasing +10,000
Viyash Scientific Limited Aug 2026 ▲ Increasing +10,000
Apollo Hospitals Enterprise Limited Aug 2026 ▼ Reducing -9,000
Torrent Pharmaceuticals Limited Aug 2026 ▼ Reducing -6,050
AstraZeneca Pharma India Limited Aug 2026 ▲ New position +6,000
Sai Life Sciences Limited Aug 2026 ▼ Reducing -5,000
Sai Parenterals Limited Aug 2026 ▲ Increasing +4,180
Abbott India Limited Aug 2026 ▼ Complete exit -2,500
Sanofi India Limited Aug 2026 ▲ Increasing +2,035
Divi's Laboratories Limited Aug 2026 ▼ Reducing -1,000
Max Healthcare Institute Limited Jul 2026 ▼ Reducing -80,000
Star Health and Allied Insurance Company Limited Jul 2026 ▼ Complete exit -80,000
J.B. Chemicals & Pharmaceuticals Lt Jul 2026 ▼ Complete exit -60,000
Sai Parenterals Limited Jul 2026 ▲ New position +56,650
Viyash Scientific Limited Jul 2026 ▲ Increasing +55,000
Thyrocare Technologies Limited Jul 2026 ▲ Increasing +40,000
Syngene International Limited Jul 2026 ▲ Increasing +30,000
Torrent Pharmaceuticals Limited Jul 2026 ▲ New position +28,050
Novartis India Limited Jul 2026 ▲ Increasing +21,958
Shilpa Medicare Limited Jul 2026 ▼ Reducing -20,000
Divi's Laboratories Limited Jul 2026 ▼ Reducing -14,000
Global Health Limited Jul 2026 ▲ Increasing +12,000
Concord Biotech Limited Jul 2026 ▼ Reducing -10,000
Inventurus Knowledge Solutions Limited Jul 2026 ▼ Complete exit -5,000
Sanofi India Limited Jul 2026 ▲ Increasing +1,965
Viyash Scientific Limited Jun 2026 ▲ New position +42,236
Mankind Pharma Limited Jun 2026 ▼ Complete exit -25,000
Sun Pharmaceutical Industries Limited Jun 2026 ▲ Increasing +25,000
Max Healthcare Institute Limited Jun 2026 ▼ Reducing -22,500
Dr. Reddy's Laboratories Limited Jun 2026 ▼ Reducing -20,000
Aurobindo Pharma Limited Jun 2026 ▲ Increasing +20,000
J.B. Chemicals & Pharmaceuticals Lt Jun 2026 ▼ Reducing -5,000
GlaxoSmithKline Pharmaceuticals Limited Jun 2026 ▲ Increasing +5,000
Apollo Hospitals Enterprise Limited Jun 2026 ▼ Reducing -3,000
Ajanta Pharma Limited Jun 2026 ▼ Reducing -3,000
Novartis India Limited Jun 2026 ▲ Increasing +2,000
Zydus Lifesciences Limited Jun 2026 ▼ Reducing -673
Abbott India Limited Jun 2026 ▲ Increasing +300
Zydus Lifesciences Limited May 2026 ▲ New position +80,000
Krishna Institute of Medical Sciences Limited May 2026 ▼ Complete exit -80,000
Aster DM Quality Care Limited May 2026 ▼ Complete exit -60,000
Healthcare Global Enterprises Limited May 2026 ▲ Increasing +56,126
Alivus Life Sciences Limited May 2026 ▲ New position +32,172
Jubilant Pharmova Limited May 2026 ▼ Complete exit -30,000
Thyrocare Technologies Limited May 2026 ▲ Increasing +30,000
Blue Jet Healthcare Limited May 2026 ▼ Complete exit -30,000
Cohance Lifesciences Limited May 2026 ▼ Complete exit -30,000
IPCA Laboratories Limited May 2026 ▲ Increasing +25,000
Shilpa Medicare Limited May 2026 ▲ Increasing +25,000
Narayana Hrudayalaya Ltd. May 2026 ▲ New position +25,000
Glenmark Pharmaceuticals Limited May 2026 ▲ Increasing +22,000
Orchid Pharma Limited May 2026 ▲ Increasing +20,000
Mankind Pharma Limited May 2026 ▼ Reducing -20,000
Lupin Limited May 2026 ▼ Reducing -12,500
Eris Lifesciences Limited May 2026 ▲ Increasing +10,000
Medi Assist Healthcare Services Limited May 2026 ▲ Increasing +10,000
Dr. Reddy's Laboratories Limited May 2026 ▼ Reducing -10,000
Sai Life Sciences Limited May 2026 ▼ Reducing -10,000
Novartis India Limited May 2026 ▲ New position +7,976
Rainbow Childrens Medicare Limited May 2026 ▲ Increasing +5,000
Divi's Laboratories Limited May 2026 ▼ Reducing -4,000
Pfizer Limited May 2026 ▲ Increasing +3,000
GlaxoSmithKline Pharmaceuticals Limited May 2026 ▲ Increasing +3,000
Sanofi India Limited May 2026 ▲ Increasing +2,000
Eris Lifesciences Limited Apr 2026 ▲ New position +35,273
Cohance Lifesciences Limited Apr 2026 ▼ Reducing -30,000
Dr. Reddy's Laboratories Limited Apr 2026 ▼ Reducing -25,000
Orchid Pharma Limited Apr 2026 ▲ Increasing +11,012
Lupin Limited Apr 2026 ▼ Reducing -10,000
Glenmark Pharmaceuticals Limited Apr 2026 ▼ Reducing -10,000
Sai Life Sciences Limited Apr 2026 ▼ Reducing -10,000
Thyrocare Technologies Limited Apr 2026 ▲ New position +10,000
Onesource Specialty Pharma Limited Mar 2026 ▼ Complete exit -25,000
J.B. Chemicals & Pharmaceuticals Lt Mar 2026 ▼ Reducing -15,000

Changes compare consecutive month-end disclosures for this portfolio only.